edaravone has been researched along with Sensitivity and Specificity in 10 studies
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prophylactic administration of edaravone exerted a significant protective effect against postoperative neurologic dysfunction after antegrade selective cerebral perfusion in a canine model with old cerebral infarction." | 7.74 | Effect of prophylactically administered edaravone during antegrade cerebral perfusion in a canine model of old cerebral infarction. ( Akuzawa, S; Bashar, AH; Fujie, M; Kazui, T; Ohishi, K; Ohkura, K; Suzuki, K; Suzuki, T; Terada, H; Washiyama, N; Yamamoto, S; Yamashita, K, 2007) |
| "Prophylactic administration of edaravone exerted a significant protective effect against postoperative neurologic dysfunction after antegrade selective cerebral perfusion in a canine model with old cerebral infarction." | 3.74 | Effect of prophylactically administered edaravone during antegrade cerebral perfusion in a canine model of old cerebral infarction. ( Akuzawa, S; Bashar, AH; Fujie, M; Kazui, T; Ohishi, K; Ohkura, K; Suzuki, K; Suzuki, T; Terada, H; Washiyama, N; Yamamoto, S; Yamashita, K, 2007) |
| "Edaravone was unstable in plasma, but it presented a good stability performance in the plasma with sodium metabisulfite (SMB), an effective antioxidant." | 1.46 | A Novel LC-MS-MS Method With an Effective Antioxidant for the Determination of Edaravone, a Free-Radical Scavenger in Dog Plasma and its Application to a Pharmacokinetic Study. ( Hu, XL; Liu, X; Shan, MT; Shao, F, 2017) |
| "Edaravone was separated on an Agilent Eclipse Plus C18 column (100×2." | 1.40 | Two complementary liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods to study the excretion and metabolic interaction of edaravone and taurine in rats. ( Bian, TT; Du, Q; Jiang, SS; Li, YJ; Tang, DQ; Yang, DZ; Yu, YY; Zheng, XX, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shao, F | 1 |
| Hu, XL | 1 |
| Liu, X | 1 |
| Shan, MT | 1 |
| Hong, SJ | 1 |
| Im, GJ | 1 |
| Chang, J | 1 |
| Chae, SW | 1 |
| Lee, SH | 1 |
| Kwon, SY | 1 |
| Jung, HH | 1 |
| Chung, AY | 1 |
| Park, HC | 1 |
| Choi, J | 1 |
| Tang, DQ | 1 |
| Zheng, XX | 1 |
| Li, YJ | 1 |
| Bian, TT | 1 |
| Yu, YY | 1 |
| Du, Q | 1 |
| Yang, DZ | 1 |
| Jiang, SS | 1 |
| Wang, YH | 1 |
| Avula, B | 1 |
| Tang, W | 1 |
| Wang, M | 1 |
| Elsohly, MA | 1 |
| Khan, IA | 1 |
| Takahashi, G | 1 |
| Sakurai, M | 1 |
| Abe, K | 1 |
| Itoyama, Y | 1 |
| Tabayashi, K | 1 |
| Aghazadeh-Habashi, A | 1 |
| Carran, J | 1 |
| Anastassiades, T | 1 |
| Jamali, F | 1 |
| Suzuki, T | 1 |
| Kazui, T | 1 |
| Yamamoto, S | 1 |
| Washiyama, N | 1 |
| Ohkura, K | 1 |
| Ohishi, K | 1 |
| Bashar, AH | 1 |
| Yamashita, K | 1 |
| Terada, H | 1 |
| Suzuki, K | 1 |
| Akuzawa, S | 1 |
| Fujie, M | 1 |
| Fu, D | 1 |
| O'Neill, RA | 1 |
| Shen, X | 1 |
| Perreault, H | 1 |
| Rozaklis, T | 1 |
| Ramsay, SL | 1 |
| Whitfield, PD | 1 |
| Ranieri, E | 1 |
| Hopwood, JJ | 1 |
| Meikle, PJ | 1 |
10 other studies available for edaravone and Sensitivity and Specificity
| Article | Year |
|---|---|
A Novel LC-MS-MS Method With an Effective Antioxidant for the Determination of Edaravone, a Free-Radical Scavenger in Dog Plasma and its Application to a Pharmacokinetic Study.
Topics: Animals; Antioxidants; Antipyrine; Chromatography, Liquid; Dogs; Edaravone; Female; Linear Models; M | 2017 |
Protective effects of edaravone against cisplatin-induced hair cell damage in zebrafish.
Topics: Animals; Antipyrine; Cell Survival; Cells, Cultured; Cisplatin; Cytoprotection; Dose-Response Relati | 2013 |
Two complementary liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods to study the excretion and metabolic interaction of edaravone and taurine in rats.
Topics: Animals; Antipyrine; Bile; Chromatography, Liquid; Drug Stability; Edaravone; Feces; Linear Models; | 2014 |
Ultra-HPLC method for quality and adulterant assessment of steviol glycosides sweeteners - Stevia rebaudiana and stevia products.
Topics: Antipyrine; Chromatography, High Pressure Liquid; Diterpenes, Kaurane; Edaravone; Food Analysis; Foo | 2015 |
MCI-186 prevents spinal cord damage and affects enzyme levels of nitric oxide synthase and Cu/Zn superoxide dismutase after transient ischemia in rabbits.
Topics: Animals; Antipyrine; Biopsy, Needle; Disease Models, Animal; Edaravone; Immunohistochemistry; Inject | 2003 |
High performance liquid chromatographic determination of N-butyryl glucosamine in rat plasma.
Topics: Administration, Oral; Animals; Antipyrine; Chromatography, High Pressure Liquid; Edaravone; Glucosam | 2005 |
Effect of prophylactically administered edaravone during antegrade cerebral perfusion in a canine model of old cerebral infarction.
Topics: Analysis of Variance; Animals; Antipyrine; Blood Chemical Analysis; Cardiopulmonary Bypass; Cerebral | 2007 |
Monosaccharide composition analysis of oligosaccharides and glycoproteins by high-performance liquid chromatography.
Topics: Antipyrine; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Edaravone; Glyco | 1995 |
Electrospray ionization mass spectrometry of 1-phenyl-3-methyl-5-pyrazolone derivatives of neutral and N-acetylated oligosaccharides.
Topics: Acetylation; Antipyrine; Chromatography, High Pressure Liquid; Edaravone; Oligosaccharides; Sensitiv | 1999 |
Determination of oligosaccharides in Pompe disease by electrospray ionization tandem mass spectrometry.
Topics: Adolescent; Adult; Antipyrine; Child; Child, Preschool; Edaravone; Glycogen Storage Disease Type II; | 2002 |